SOLICITATION NOTICE
Q -- Post-Accident Toxicological Testing of Human Samples and Related Services
- Notice Date
- 11/7/2006
- Notice Type
- Solicitation Notice
- NAICS
- 621511
— Medical Laboratories
- Contracting Office
- Department of Transportation, Federal Railroad Administration (FRA), Office of Acquisition and Grants Services, 1120 Vermont Avenue, NW Mail Stop 50, Washington, DC, 20590, UNITED STATES
- ZIP Code
- 00000
- Solicitation Number
- DTFR53-1106
- Response Due
- 11/21/2006
- Archive Date
- 12/6/2006
- Description
- The Federal Railroad Administration (FRA), intends to negotiate a base year with four (4) one-year option periods for the toxicology analysis of samples obtained from various railroad employees subject to FRA?s mandatory Post-Accident Toxicology Testing Program as implemented pursuant to Title 49 Code of Federal Regulations (CFR) Part 219 Control of Alcohol and Drug Use. To be eligible for award, a prospective offeror must have prior to award, Department of Health and Human Services/Substance Abuse and Mental Health Services Administration (DHHS/SAMHSA) certification for the laboratory proposed and licensure under the Clinical Laboratory Improvement Act (CLIA). The FRA requires special testing of rail crews to determine if drugs or alcohol were either a primary or contributing cause to a significant rail accident or incident. Samples are collected by carrier-selected medical facilities using FRA mandatory post-accident split-sample toxicology kits. Specimens include urine and whole blood for surviving crew members, and urine, whole blood, and tissue for deceased crew members. Samples are analyzed by utilizing FRA-established cut-offs in urine and whole blood, and results obtained must be scientifically sound and legally defensible. This program does not fall under 49 CFR Part 40 authority, it is specifically excluded. Analyses of specimen sets from approximately 250 employees after 80 ? 100 events are projected for each performance period (base & options) under the anticipated contract. The successful offeror?s laboratory must be capable of the following: (A) Receiving and preserving specimen sets 24 hours a day, seven days a week, either at its laboratory or through some other FRA-approved, forensically acceptable manner. (B) Accessioning specimens and implementing strict chain-of-custody procedures. (C) Analyzing specimen sets based on FRA-approved screening and confirmatory protocols. Urines are to be screened for drugs of interest by an approved immunoassay (e.g. KIMS, EIA, RIA or FPIA). Presumptive drug positives are to be confirmed in urine by Gas Chromatography/Mass Spectrometry (GC/MS). The corresponding whole blood is to be evaluated by GC/MS for any confirmed urine positive drug group. Where no acceptable urine sample exists, the laboratory must have the capability to directly screen the whole blood using an acceptable immunoassay procedure. For deceased crew members, the laboratory must also have the capability to screen and confirm for the presence of drugs and alcohol in various other body fluids and tissues, including vitreous, brain, liver, etc. Whole blood samples will always be directly evaluated by headspace Gas Chromatography (or equivalent) for the presence of ethyl alcohol. The laboratory will also be responsible for screening/testing of adulterants and substitutions consistent with DHHS/SAMHSA guidelines. For negative drug screens (regardless of the alcohol results), reports are to be issued as a group, no later than three working days after receipt of samples of surviving crew members, and five working days where one or more fatalities are involved. For cases with presumptive positive on screening tests, reports are to be issued as a group, no later than ten days after receipt of samples. Prospective offerors failing to meet the certification, licensure, and/or technical capability requirements identified in the solicitation will not be considered. As of the release/posting of this notice, it is anticipated that on or about November 28, 2006 the subject solicitation will be issued (i.e. made available) in electronic media and posted to the Federal Business Opportunities (FedBizOpps) website (formerly known as Electronic Posting System (EPS)). Once posted, the solicitation may be download or printed from the following Internet address: http://www.fedbizopps.gov/ (the same site is also accessible/co-located at http://www.eps.gov). The FRA does not intend to make the solicitation available in hard copy. (Note: The anticipated solicitation release date cited above is a target date and is provided for information purposes only. The actual date of posting of the solicitation at FedBizOpps may be before, on, or after that date). As of the release/posting of this notice, it is anticipated that the closing date for receipt of offers for the subject solicitation will be on or about January 11, 2007 (Note: The anticipated solicitation closing date cited above is a target date and is provided for information purposes only. The solicitation and the solicitation alone, shall establish and specify the closing or due date for receipt of offers). FRA will accept, review and evaluate proposals that provide services for 1) the Screening and Confirmatory Drug and Alcohol Tests in Urine & Blood; 2) the Post-Accident Toxicological Testing System; and 3) the Manufacture, Warehousing and Shipment of FRA Post-Accident Toxicology Boxes. This is an unrestricted, competitive procurement. All eligible, responsible sources may submit a proposal which shall be considered by the Agency.
- Record
- SN01177296-W 20061109/061107220309 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |